http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009538272-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-08 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 |
| filingDate | 2007-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2009538272-A |
| titleOfInvention | Improved dosing and scheduling of oligomers |
| abstract | The present invention relates to a human having a proliferative disease by administering an effective amount of pretreatment to a patient prior to administering an effective amount of a nucleotide-based composition that suppresses overexpression of a target gene that causes the proliferative disease. It relates to a method for treating a patient. The present invention includes pretreatment with one or more of radiotherapy such as X-rays, proton beams, electron beams, hyperthermia, ultrasound therapy, chemotherapy, and biological therapy. The invention also relates to an improved dosing and scheduling sequence for treating patients in need of treatment with a nucleotide-based inhibitor of the gene expression of interest. |
| priorityDate | 2006-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 174.